![Richard Collier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Collier
Direktor/Vorstandsmitglied bei
PROTHENA CORPORATION PLC
Vermögen: 9 898 $ am 31.07.2026
Profil
Richard T.
Collier is an Independent Director at Prothena Corp.
Plc since 2012.
Formerly, Mr. Collier was Executive Vice President & General Counsel at Elan Corp.
Plc from 2004 to 2010, Senior Vice President & General Counsel at Pharmacia & Upjohn Co. LLC from 1997 to 2000, Senior Vice President & General Counsel at Pharmacia Corp.
from 2000 to 2003, Senior Vice President & General Counsel at Rhone-Poulenc Rorer, Inc. from 1990 to 1997, and Professor at Temple University Beasley School of Law from 2004 to 2017.
Education includes undergraduate and graduate degrees from Temple University (Pennsylvania).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.05.2026 | 1 219 ( 0 % ) | 9 898 $ | 31.07.2026 |
Aktive Positionen von Richard Collier
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTHENA CORPORATION PLC | Direktor/Vorstandsmitglied | 20.12.2012 |
Ehemalige bekannte Positionen von Richard Collier
| Unternehmen | Position | Ende |
|---|---|---|
Temple University Beasley School of Law
 Temple University Beasley School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2017 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | General Counsel | 01.01.2010 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | General Counsel | 01.04.2003 |
Pharmacia & Upjohn Co. LLC
 Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | General Counsel | 01.01.2000 |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | General Counsel | 01.01.1997 |
Ausbildung von Richard Collier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Health Technology |
Temple University Beasley School of Law
Temple University Beasley School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
